OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Quick Stats
Jan 30, 202647.8
AI Score
HOLD1.22
Volume Ratio
Feb 25, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
OKYO Stock Summary
Last updated Jan 30, 2026
OKYO is currently trading at $2.05, positioned below its 200-day moving average of $2.21, suggesting bearish momentum. The stock has a 52-week range of $0.9016 to $3.349.
Technical Analysis: The 50-day moving average stands at $2.13, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.905, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.127, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OKYO at 47.8/100 with a HOLD recommendation.
OKYO (OKYO Pharma Limited Ordinary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.905 |
| CMF (20) | -0.127 |
| ROC (10) | -14.226 |
| ADX (14) | 27.09 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.03 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -90.551 |
| MFI (14) | 45.157 |
OKYO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OKYO Price vs Max Options Open Interest
OKYO Max Change In Options Open Interest
OKYO Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OKYO Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OKYO Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OKYO Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OKYO Pharma Limited Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
OKYO Moving Averages Analysis
OKYO (OKYO Pharma Limited Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.16 |
| 20 | 2.34 |
| 30 | 2.23 |
| 50 | 2.13 |
| 100 | 2.2 |
| 200 | 2.21 |
OKYO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 89.9 million |
| Earnings/Share ($) | -0.12 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.185 |
| EPS Estimate Next Year ($) | -0.28 |
| WallStreet Target Price ($) | 10 |
| Most Recent Quarter |